{"pmid":32330565,"title":"Donning a new approach to the practice of gastroenterology: perspectives from the COVID-19 pandemic epicenter.","text":["Donning a new approach to the practice of gastroenterology: perspectives from the COVID-19 pandemic epicenter.","The COVID-19 pandemic is seemingly peaking now in New York City and has triggered significant changes to the standard management of gastrointestinal diseases. Priorities such as minimizing viral transmission, preserving (personal protective equipment) PPE, and freeing hospital beds have driven unconventional approaches to managing GI patients. Conversion of endoscopy units to COVID units and redeployment of gastroenterology (GI) fellows and faculty has profoundly changed the profile of most GI services. Meanwhile, consult and procedural volumes have been drastically reduced. In this review we share our collective experiences, how we have changed our practice of medicine, in response to the COVID surge. While we will review our management of specific consults and conditions, the overarching theme focuses primarily on non-invasive measures and maximizing medical therapies. Endoscopic procedures have been reserved for those timely interventions that are most likely to be therapeutic. The role of multidisciplinary discussion, while always important, has now become critical. And the support of our faculty and trainees remains essential. Local leadership can encourage well-being by frequent team check-ins and foster trainee development through remote learning. Advancing a clear vision and a transparent process for how to organize and triage care in the recovery phase will allow for a smooth transition to our \"new normal.\"","Clin Gastroenterol Hepatol","Sethi, Amrita","Swaminath, Arun","Latorre, Melissa","Behin, Daniel S","Jodorkovsky, Daniela","Calo, Delia","Aroniadis, Olga","Mone, Anjali","Mendelsohn, Robin B","Sharaiha, Reem Z","Gonda, Tamas A","Khanna, Lauren G","Bucobo, Juan Carlos","Nagula, Satish","Ho, Sammy","Carr-Locke, David L","Robbins, David H","32330565"],"abstract":["The COVID-19 pandemic is seemingly peaking now in New York City and has triggered significant changes to the standard management of gastrointestinal diseases. Priorities such as minimizing viral transmission, preserving (personal protective equipment) PPE, and freeing hospital beds have driven unconventional approaches to managing GI patients. Conversion of endoscopy units to COVID units and redeployment of gastroenterology (GI) fellows and faculty has profoundly changed the profile of most GI services. Meanwhile, consult and procedural volumes have been drastically reduced. In this review we share our collective experiences, how we have changed our practice of medicine, in response to the COVID surge. While we will review our management of specific consults and conditions, the overarching theme focuses primarily on non-invasive measures and maximizing medical therapies. Endoscopic procedures have been reserved for those timely interventions that are most likely to be therapeutic. The role of multidisciplinary discussion, while always important, has now become critical. And the support of our faculty and trainees remains essential. Local leadership can encourage well-being by frequent team check-ins and foster trainee development through remote learning. Advancing a clear vision and a transparent process for how to organize and triage care in the recovery phase will allow for a smooth transition to our \"new normal.\""],"journal":"Clin Gastroenterol Hepatol","authors":["Sethi, Amrita","Swaminath, Arun","Latorre, Melissa","Behin, Daniel S","Jodorkovsky, Daniela","Calo, Delia","Aroniadis, Olga","Mone, Anjali","Mendelsohn, Robin B","Sharaiha, Reem Z","Gonda, Tamas A","Khanna, Lauren G","Bucobo, Juan Carlos","Nagula, Satish","Ho, Sammy","Carr-Locke, David L","Robbins, David H"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330565","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.cgh.2020.04.032","keywords":["covid-19","consults","experience","guidelines","nysge","ppe"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664996914978881536,"score":8.518259,"similar":[{"pmid":32327904,"pmcid":"PMC7167410","title":"SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant.","text":["SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant.","The current pandemic due to the severe acute respiratory syndrome coronavirus 2 has caused an extreme burden for health care systems globally, and the number of cases is expected to continue to increase, at least in the immediate future. The virus is estimated to have infected more than 1.5 million individuals. The available reports suggest that gastrointestinal (GI) involvement in coronavirus disease 2019 (COVID-19) is common and in some cases the GI symptoms may precede the respiratory symptoms. In addition to direct effects of severe acute respiratory syndrome coronavirus 2, the infected patients remain at risk for the complications commonly managed by gastroenterology and hepatology consultants. The most commonly reported GI manifestation of COVID-19 is diarrhea, which is reported in a third to up to more than half of the patients. Mild to moderate elevation of the liver enzymes are also common, although no case of acute liver failure has been reported so far. Many of the medications used for treatment of COVID-19 can also be associated with GI symptoms or liver injury and can be included in the differential diagnosis in these patients. Although the diagnosis of the infection is currently based on RNA analysis in respiratory samples, the available literature on fecal shedding of this virus suggests that fecal RNA testing might prove to be a useful diagnostic test. It is reasonable to delay all non-urgent endoscopic procedures during the peak of the pandemic and use additional protective equipment such as N95 respirators during endoscopy while most patients can be considered high risk for having been exposed to the virus.","World J Gastroenterol","Hajifathalian, Kaveh","Mahadev, Srihari","Schwartz, Robert E","Shah, Shawn","Sampath, Kartik","Schnoll-Sussman, Felice","Brown, Robert S Jr","Carr-Locke, David","Cohen, David E","Sharaiha, Reem Z","32327904"],"abstract":["The current pandemic due to the severe acute respiratory syndrome coronavirus 2 has caused an extreme burden for health care systems globally, and the number of cases is expected to continue to increase, at least in the immediate future. The virus is estimated to have infected more than 1.5 million individuals. The available reports suggest that gastrointestinal (GI) involvement in coronavirus disease 2019 (COVID-19) is common and in some cases the GI symptoms may precede the respiratory symptoms. In addition to direct effects of severe acute respiratory syndrome coronavirus 2, the infected patients remain at risk for the complications commonly managed by gastroenterology and hepatology consultants. The most commonly reported GI manifestation of COVID-19 is diarrhea, which is reported in a third to up to more than half of the patients. Mild to moderate elevation of the liver enzymes are also common, although no case of acute liver failure has been reported so far. Many of the medications used for treatment of COVID-19 can also be associated with GI symptoms or liver injury and can be included in the differential diagnosis in these patients. Although the diagnosis of the infection is currently based on RNA analysis in respiratory samples, the available literature on fecal shedding of this virus suggests that fecal RNA testing might prove to be a useful diagnostic test. It is reasonable to delay all non-urgent endoscopic procedures during the peak of the pandemic and use additional protective equipment such as N95 respirators during endoscopy while most patients can be considered high risk for having been exposed to the virus."],"journal":"World J Gastroenterol","authors":["Hajifathalian, Kaveh","Mahadev, Srihari","Schwartz, Robert E","Shah, Shawn","Sampath, Kartik","Schnoll-Sussman, Felice","Brown, Robert S Jr","Carr-Locke, David","Cohen, David E","Sharaiha, Reem Z"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327904","week":"202017|Apr 20 - Apr 26","doi":"10.3748/wjg.v26.i14.1546","keywords":["covid-19","gastroenterology","hepatology","liver","sars-cov-2"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664996914785943552,"score":385.35236},{"pmid":32335946,"title":"Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","text":["Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19.","Dig Endosc","Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro","32335946"],"abstract":["All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19."],"journal":"Dig Endosc","authors":["Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335946","week":"202018|Apr 27 - May 03","doi":"10.1111/den.13703","keywords":["covid-19","corona virus","gastrointestinal endoscopy","personal protective equipment"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Japan","anesthesia","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"_version_":1665172301964902401,"score":369.95255},{"pmid":32281689,"title":"COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","text":["COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures.","Dig Endosc","Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant","32281689"],"abstract":["A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures."],"journal":"Dig Endosc","authors":["Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281689","week":"202016|Apr 13 - Apr 19","doi":"10.1111/den.13693","keywords":["covid-19","coronavirus","sars-cov-2","endoscopy","pandemic"],"source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["Wuhan","China","China","United States","US","US"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"_version_":1664636703936086016,"score":339.73083},{"pmid":32304561,"title":"Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper.","text":["Pediatric Endoscopy in the Era of Coronavirus Disease 2019: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper.","The delivery of endoscopic care is changing rapidly in the era of Coronavirus Disease 2019 (COVID-19). The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Endoscopy and Procedures Committee has formulated this statement to offer practical guidance to help standardize endoscopy services for pediatric patients with the aim of minimizing COVID-19 transmission to staff, patients, and caregivers and to conserve personal protective equipment (PPE) during this critical time. Appropriate use of PPE is essential to minimize transmission and preserve supply. Pediatric endoscopic procedures are considered at high risk for COVID-19 transmission. We recommend that all pediatric endoscopic procedures are done in a negative pressure room with all staff using proper airborne, contact, and droplet precautions regardless of patient risk stratification. This includes appropriate use of a filtering face-piece respirator (N95, N99, FFP2/3, or PAPR), double gloves, facial protection (full visor and/or face shield), full body water-resistant disposable gown, shoe covers and a hairnet. In deciding which endoscopic procedures should proceed, it is important to weigh the risks and benefits to optimize healthcare delivery and minimize risk. To inform these decisions, we propose a framework for stratifying procedures as emergent (procedures that need to PROCEEED), urgent (PAUSE, weigh the benefits and risks in deciding whether to proceed) and elective (POSTPONE procedures). This statement was based on emerging evidence and is meant as a guide. It is important that all endoscopy facilities where pediatric procedures are performed follow current recommendations from public health agencies within their jurisdiction regarding infection prevention and control of COVID-19.","J Pediatr Gastroenterol Nutr","Walsh, Catharine M","Fishman, Douglas S","Lerner, Diana G","32304561"],"abstract":["The delivery of endoscopic care is changing rapidly in the era of Coronavirus Disease 2019 (COVID-19). The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Endoscopy and Procedures Committee has formulated this statement to offer practical guidance to help standardize endoscopy services for pediatric patients with the aim of minimizing COVID-19 transmission to staff, patients, and caregivers and to conserve personal protective equipment (PPE) during this critical time. Appropriate use of PPE is essential to minimize transmission and preserve supply. Pediatric endoscopic procedures are considered at high risk for COVID-19 transmission. We recommend that all pediatric endoscopic procedures are done in a negative pressure room with all staff using proper airborne, contact, and droplet precautions regardless of patient risk stratification. This includes appropriate use of a filtering face-piece respirator (N95, N99, FFP2/3, or PAPR), double gloves, facial protection (full visor and/or face shield), full body water-resistant disposable gown, shoe covers and a hairnet. In deciding which endoscopic procedures should proceed, it is important to weigh the risks and benefits to optimize healthcare delivery and minimize risk. To inform these decisions, we propose a framework for stratifying procedures as emergent (procedures that need to PROCEEED), urgent (PAUSE, weigh the benefits and risks in deciding whether to proceed) and elective (POSTPONE procedures). This statement was based on emerging evidence and is meant as a guide. It is important that all endoscopy facilities where pediatric procedures are performed follow current recommendations from public health agencies within their jurisdiction regarding infection prevention and control of COVID-19."],"journal":"J Pediatr Gastroenterol Nutr","authors":["Walsh, Catharine M","Fishman, Douglas S","Lerner, Diana G"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32304561","week":"202016|Apr 13 - Apr 19","doi":"10.1097/MPG.0000000000002750","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["North American"],"e_drugs":["Water"],"_version_":1664632934635667456,"score":328.2339},{"pmid":32298146,"title":"Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.","text":["Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective.","In response to the estimated potential impact of COVID-19 on New York City hospitals, our institution prepared for an influx of critically ill patients. Multiple areas of surge planning progressed simultaneously focused on infection control, clinical operational challenges, intensive care unit surge capacity, staffing, ethics and maintenance of staff wellness. Protocols developed focused on clinical decisions around intubation, the use of high-flow oxygen, infectious disease consultation and cardiac arrest. Mechanisms to increase bed capacity as well as increase efficiency in intensive care units by outsourcing procedures were implemented. Novel uses of technology to minimize staff exposure to COVID-19, as well as to facilitate family engagement and end of life discussions were encouraged. Education and communication remained key in attempting to standardize care, stay apprized on emerging data as well as to review seminal literature on respiratory failure. Challenges were encountered, and overcome through interdisciplinary collaboration and iterative surge planning as intensive care unit admissions rose. Support was provided for both clinical and nonclinical staff affected by the profound impact COVID-19 had on our city. We describe in granular detail, the procedures and processes developed during a one month period while surge planning was ongoing and the need for intensive care unit capacity rose exponentially. The approaches described provide a potential roadmap for centers that must rapidly adapt to the tremendous challenge introduced by this and potential future pandemics. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).","Am J Respir Crit Care Med","Griffin, Kelly M","Karas, Maria G","Ivascu, Natalia S","Lief, Lindsay","32298146"],"abstract":["In response to the estimated potential impact of COVID-19 on New York City hospitals, our institution prepared for an influx of critically ill patients. Multiple areas of surge planning progressed simultaneously focused on infection control, clinical operational challenges, intensive care unit surge capacity, staffing, ethics and maintenance of staff wellness. Protocols developed focused on clinical decisions around intubation, the use of high-flow oxygen, infectious disease consultation and cardiac arrest. Mechanisms to increase bed capacity as well as increase efficiency in intensive care units by outsourcing procedures were implemented. Novel uses of technology to minimize staff exposure to COVID-19, as well as to facilitate family engagement and end of life discussions were encouraged. Education and communication remained key in attempting to standardize care, stay apprized on emerging data as well as to review seminal literature on respiratory failure. Challenges were encountered, and overcome through interdisciplinary collaboration and iterative surge planning as intensive care unit admissions rose. Support was provided for both clinical and nonclinical staff affected by the profound impact COVID-19 had on our city. We describe in granular detail, the procedures and processes developed during a one month period while surge planning was ongoing and the need for intensive care unit capacity rose exponentially. The approaches described provide a potential roadmap for centers that must rapidly adapt to the tremendous challenge introduced by this and potential future pandemics. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)."],"journal":"Am J Respir Crit Care Med","authors":["Griffin, Kelly M","Karas, Maria G","Ivascu, Natalia S","Lief, Lindsay"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298146","week":"202016|Apr 13 - Apr 19","doi":"10.1164/rccm.202004-1037CP","keywords":["sars virus","intensive care units","pandemics"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["New York"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664641388417908736,"score":303.18307}]}